Laryngeal Diseases
5 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Curcumin for laryngostenosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Petosemtamab for laryngeal diseases | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Simultaneous-Integrated Boost Intensity-Modulated Radiation Therapy + Volume Modulated Arc Therapy + NIVOLUMAB + IPILIMUMAB for laryngeal diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VMD-928 100 mg Tablet for laryngeal diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| VMD-928 Tablet and Pembrolizumab (200 mg) for laryngeal diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |